307 related articles for article (PubMed ID: 17952355)
1. [Chronic renal disease, inflammation and atherosclerosis: new concepts about an old problem].
Dummer CD; Thomé FS; Veronese FV
Rev Assoc Med Bras (1992); 2007; 53(5):446-50. PubMed ID: 17952355
[TBL] [Abstract][Full Text] [Related]
2. Protecting the endothelium: a new focus for management of chronic kidney disease.
Diaz-Buxo JA; Woods HF
Hemodial Int; 2006 Jan; 10(1):42-8. PubMed ID: 16441826
[TBL] [Abstract][Full Text] [Related]
3. Uremic Toxins, Oxidative Stress, Atherosclerosis in Chronic Kidney Disease, and Kidney Transplantation.
Wojtaszek E; Oldakowska-Jedynak U; Kwiatkowska M; Glogowski T; Malyszko J
Oxid Med Cell Longev; 2021; 2021():6651367. PubMed ID: 33628373
[TBL] [Abstract][Full Text] [Related]
4. Atherosclerosis in CKD: differences from the general population.
Drüeke TB; Massy ZA
Nat Rev Nephrol; 2010 Dec; 6(12):723-35. PubMed ID: 20978469
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress, inflammation and cardiovascular disease in chronic renal failure.
Cottone S; Lorito MC; Riccobene R; Nardi E; Mulè G; Buscemi S; Geraci C; Guarneri M; Arsena R; Cerasola G
J Nephrol; 2008; 21(2):175-9. PubMed ID: 18446711
[TBL] [Abstract][Full Text] [Related]
6. Inflammation modifies the association of osteoprotegerin with mortality in chronic kidney disease.
Matsubara K; Stenvinkel P; Qureshi AR; Carrero JJ; Axelsson J; Heimbürger O; Bárány P; Alvestrand A; Lindholm B; Suliman ME
J Nephrol; 2009; 22(6):774-82. PubMed ID: 19967657
[TBL] [Abstract][Full Text] [Related]
7. [Malnutrition -- inflammation -- atherosclerosis (MIA syndrome) in patients with renal failure].
Pawlaczyk K; Oko A; Lindholm B; Czekalski S
Pol Merkur Lekarski; 2003 Oct; 15(88):334-41; discussion 341-3. PubMed ID: 14974361
[TBL] [Abstract][Full Text] [Related]
8. Malnutrition-inflammation-atherosclerosis syndrome in patients with end-stage renal disease.
Zyga S; Christopoulou G; Malliarou M
J Ren Care; 2011 Mar; 37(1):12-5. PubMed ID: 21288312
[TBL] [Abstract][Full Text] [Related]
9. The role of oxidative stress-altered lipoprotein structure and function and microinflammation on cardiovascular risk in patients with minor renal dysfunction.
Kaysen GA; Eiserich JP
J Am Soc Nephrol; 2004 Mar; 15(3):538-48. PubMed ID: 14978155
[TBL] [Abstract][Full Text] [Related]
10. Vascular disease and chronic renal failure: new insights.
Nanayakkara PW; Gaillard CA
Neth J Med; 2010 Jan; 68(1):5-14. PubMed ID: 20103816
[TBL] [Abstract][Full Text] [Related]
11. Interactions between inflammation, oxidative stress, and endothelial dysfunction in end-stage renal disease.
Stenvinkel P
J Ren Nutr; 2003 Apr; 13(2):144-8. PubMed ID: 12671839
[TBL] [Abstract][Full Text] [Related]
12. Epidemiology of vascular disease in renal failure.
Ikizler TA
Blood Purif; 2002; 20(1):6-10. PubMed ID: 11803153
[TBL] [Abstract][Full Text] [Related]
13. Traditional and non-traditional risk factors as contributors to atherosclerotic cardiovascular disease in end-stage renal disease.
Yao Q; Pecoits-Filho R; Lindholm B; Stenvinkel P
Scand J Urol Nephrol; 2004; 38(5):405-16. PubMed ID: 15764253
[TBL] [Abstract][Full Text] [Related]
14. Linking oxidative stress and inflammation in kidney disease: which is the chicken and which is the egg?
Himmelfarb J
Semin Dial; 2004; 17(6):449-54. PubMed ID: 15660575
[TBL] [Abstract][Full Text] [Related]
15. Role of nutrition for cardiovascular risk reduction in chronic kidney disease patients.
Ikizler TA
Adv Chronic Kidney Dis; 2004 Apr; 11(2):162-71. PubMed ID: 15216487
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular effects of uremia in apolipoprotein E-deficient mice.
Bro S
Dan Med Bull; 2009 Nov; 56(4):177-92. PubMed ID: 19939336
[TBL] [Abstract][Full Text] [Related]
17. Relevance of oxidative pathways in the pathophysiology of chronic kidney disease.
Himmelfarb J
Cardiol Clin; 2005 Aug; 23(3):319-30. PubMed ID: 16084281
[TBL] [Abstract][Full Text] [Related]
18. Label-Free Quantitative Proteomics Reveals Differences in Molecular Mechanism of Atherosclerosis Related and Non-Related to Chronic Kidney Disease.
Luczak M; Suszynska-Zajczyk J; Marczak L; Formanowicz D; Pawliczak E; Wanic-Kossowska M; Stobiecki M
Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27144566
[TBL] [Abstract][Full Text] [Related]
19. [Atherosclerosis and uremia: signifance of non-traditional risk factors].
Hörl WH
Wien Klin Wochenschr; 2003 Apr; 115(7-8):220-34. PubMed ID: 12778774
[TBL] [Abstract][Full Text] [Related]
20. Chronic systemic inflammation in dialysis patients: an update on causes and consequences.
Yao Q; Axelsson J; Stenvinkel P; Lindholm B
ASAIO J; 2004; 50(6):lii-lvii. PubMed ID: 15672781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
